Rachel Foot

Rachel A. Foot , MD

Assistant Professor of Clinical

Internal Medicine
Medical Sciences Building Room 6352D
231 Albert Sabin Way
Cincinnati, Ohio 45267
Phone 513-558-4831
Email rachel.foot@uc.edu


Medical Degree: The University of Toledo College of Medicine Toledo, OH,

Bachelor's Degree: University of Michigan Ann Arbor, MI, (Movement Science and Latin Language, Litterature, and Culture minor)

Residency: University of Cincinnati Cincinnati, OH, 2015 (Internal Medicine)

Fellowship: University of Cincinnati Cincinnati, OH, 2015 (Pulmonary)

Fellowship: University of Cincinnati Cincinnati, OH, 2018 (Pulmonary & Critical Care)


American Board of Internal Medicine (Critical Care Medicine) (Certification Date: 11-12-2018 )

American Board of Internal Medicine (Certification Date: 08-12-2015 )

American Board of Internal Medicine (Pulmonary Disease) (Certification Date: 10-19-2017 )

Clinical Interests

Critical Care Medicine

Lung Disease

Pulmonary Disease

Rare Lung Disease




Chronic Cough



Idiopathic Pulmonary Fibrosis

Interstitial Lung Disease (ILD)

Legionnaires' Disease (Legionellosis)




Pulmonary Fibrosis

Pulmonary Sarcoidosis

Respiration Disorders

Respiratory Syncytial Virus (RSV)

Respiratory Tract Disease

Respiratory Tract Infections

Shortness of Breath

Thoracic Disease


Whooping Cough (Pertussis)


Critical Care Medicine

Internal Medicine

Research and Practice Interests

Interstitial Lung Disease, Critical Care


Research Support

Grant: #Duke; tba; 10T2HL156812-01; RECOVER-VIAL Investigators:Becker, Richard; Foot, Rachel -06-30-2024 National Heart, Lung and Blood Institute RECOVER-VITAL: A Platform Protocol for Evaluation of Interventions for Viral Persistence, Viral Reactivation, and Immune Dysregulation in Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) Role:Collaborator 0.00 Hold Level:Federal

Investigators:Foot, Rachel 09-29-2023 -09-28-2026 Third Pole Therapeutics A Within subject Device setting Escalation Early Feasibility Study Evaluating the Safety, Tolerability, and Functionality of 3P-100, an Electric Nitric Oxide (NO) Ambulatory Production and Delivery Sy Role:PI 0.00 Hold Level:Industry


Peer Reviewed Publications

Osterburg, Andrew R; Nelson, Rebecca L; Yaniv, Benyamin Z; Foot, Rachel; Donica, Walter R F; Nashu, Madison A; Liu, Huan; Wikenheiser-Brokamp, Kathryn A; Moss, Joel; Gupta, Nishant; McCormack, Francis X; Borchers, Michael T (2016. ) NK cell activating receptor ligand expression in lymphangioleiomyomatosis is associated with lung function decline.JCI insight, , 1 (16 ) ,e87270 More Information

Contact Information

Academic - Internal Medicine
Medical Sciences Building Room 6352D
Cincinnati  Ohio, 45267
Phone: 513-558-4831